Tuesday, September 1, 2026
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Cancer

Mendoza, Weiss receive $2.6 million grant to study biomechanics of lung tumors

July 15, 2024
in Cancer
Nathaniel Bowman
By Nathaniel Bowman Scienmag Editorial Profile - Precision Oncology
Reading Time: 4 mins read
0
Mendoza, Weiss receive $2.6 million grant to study biomechanics of
67
SHARES
612
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

Michelle Mendoza, PhD, researcher at Huntsman Cancer Institute and associate professor of oncological sciences at the University of Utah (the U) and Jeffrey Weiss, PhD, professor of biomedical engineering and faculty member in the Scientific Computing and Imaging Institute at the U, are the recipients of a $2.6 million grant from the National Institutes of Health (NIH) to research how tension in lung tissue affects the growth and distribution of tumors. This innovative approach could uncover new mechanisms for understanding how lung cancer develops. 

Michelle Mendoza

Credit: Huntsman Cancer Institute

Michelle Mendoza, PhD, researcher at Huntsman Cancer Institute and associate professor of oncological sciences at the University of Utah (the U) and Jeffrey Weiss, PhD, professor of biomedical engineering and faculty member in the Scientific Computing and Imaging Institute at the U, are the recipients of a $2.6 million grant from the National Institutes of Health (NIH) to research how tension in lung tissue affects the growth and distribution of tumors. This innovative approach could uncover new mechanisms for understanding how lung cancer develops. 

“There are a lot of people looking at the stiffness of breast tissue or other material properties and other types of cancers, but not so much in the lung. And it’s interesting, because the lung is always undergoing stretch as we breathe in and out. There’s not a lot of tissues that have that characteristic,” says Mendoza.

The study examines the role of mechanobiology—an emerging field that explores how cells respond to mechanical signals—in the progression of early benign lesions to lung adenocarcinoma. According to the American Cancer Society, adenocarcinoma is the most common subtype of non-small cell lung cancer. 

The researchers simulated how the presence of a solid tumor fills and affects alveolar sacs, where lungs and blood exchange oxygen for carbon dioxide, using computational models developed in Weiss’s lab.

They observed that the connective tissues making up the walls of the sacs are sensitive to strain—which may produce a cellular response that allows the tumor to grow.

“It’s a new hypothesis about something that’s contributing to the early tumor cells progressing to malignancy, which other people haven’t looked at,” says Mendoza. “And it would be a really interesting discovery if it’s contributing to tumor development—because strain could be affected by things in our environment that cause lung damage or scarring.”

The NIH grant allows Mendoza and Weiss to conduct their research experimentally by testing the effects directly in tissue and also develop more advanced computer models.

Weiss has worked in biomechanics for decades, particularly in musculoskeletal science and cardiovascular mechanics.

“It’s gratifying for me that at this point in my career, I can still do different and new things that are interesting to me,” says Weiss. “I’m pleased to see that the tools that I’ve developed over my career are useful in this context, as well.”

The $2.6 million grant will be distributed over the next five years. Mendoza and Weiss hope the study will lead to further explorations of mechanobiology, as well as the development of neoadjuvant therapies to reduce lung cancer mortality.

About Huntsman Cancer Institute at the University of Utah

Huntsman Cancer Institute at the University of Utah (the U) is the National Cancer Institute-designated Comprehensive Cancer Center for Utah, Idaho, Montana, Nevada, and Wyoming. With a legacy of innovative cancer research, groundbreaking discoveries, and world-class patient care, we are transforming the way cancer is understood, prevented, diagnosed, treated, and survived. Huntsman Cancer Institute focuses on delivering a cancer-free frontier to all communities in the area we serve. We have more than 300 open clinical trials and 250 research teams studying cancer at any given time. More genes for inherited cancers have been discovered at Huntsman Cancer Institute than at any other cancer center. Our scientists are world-renowned for understanding how cancer begins and using that knowledge to develop innovative approaches to treat each patient’s unique disease. Huntsman Cancer Institute was founded by Jon M. and Karen Huntsman.  



Subject of Research: Cancer

Article Title: Mendoza, Weiss receive $2.6 million grant to study biomechanics of lung tumors

Article References: Original research article

Image Credits: AI Generated

DOI: Not provided

Keywords: Not provided

Cite Scienmag News

Nathaniel Bowman. (July 15, 2024). Mendoza, Weiss receive $2.6 million grant to study biomechanics of lung tumors. Scienmag. https://scienmag.com/mendoza-weiss-receive-2-6-million-grant-to-study-biomechanics-of-lung-tumors/

Nathaniel Bowman. "Mendoza, Weiss receive $2.6 million grant to study biomechanics of lung tumors." Scienmag, 15 July 2024, https://scienmag.com/mendoza-weiss-receive-2-6-million-grant-to-study-biomechanics-of-lung-tumors/. Accessed 1 September 2026.

Nathaniel Bowman. "Mendoza, Weiss receive $2.6 million grant to study biomechanics of lung tumors." Scienmag. July 15, 2024. https://scienmag.com/mendoza-weiss-receive-2-6-million-grant-to-study-biomechanics-of-lung-tumors/

Share27Tweet17
Previous Post

National Institutes of Health grant could mean progress toward improved outcomes for stroke patients

Next Post

University of Cincinnati study: Long-term stroke survival improving, but racial disparities remain

Related Posts

GALNT5 fuels colorectal cancer growth and drug resistance through PI3K/Akt/ABCC1 pathway
Cancer

GALNT5 fuels colorectal cancer growth and drug resistance through PI3K/Akt/ABCC1 pathway

August 31, 2026
Untangling chromosomal and hormonal effects to make sex-specific endothelial OCT4 clinically actionable
Cancer

Untangling chromosomal and hormonal effects to make sex-specific endothelial OCT4 clinically actionable

August 30, 2026
Waldenström’s macroglobulinemia in siblings: 25 years of institutional cases reviewed
Cancer

Waldenström’s macroglobulinemia in siblings: 25 years of institutional cases reviewed

August 30, 2026
BEGONIA trial: durvalumab plus trastuzumab deruxtecan for HER2-low metastatic breast cancer
Cancer

BEGONIA trial: durvalumab plus trastuzumab deruxtecan for HER2-low metastatic breast cancer

August 30, 2026
2026 RISE UP Conference Targets Breast Cancer and Women’s Health Advances
Cancer

2026 RISE UP Conference Targets Breast Cancer and Women’s Health Advances

August 30, 2026
Mogrosides regulate tumor metabolism and immune response, revealing dual anticancer mechanism
Cancer

Mogrosides regulate tumor metabolism and immune response, revealing dual anticancer mechanism

August 30, 2026
Next Post
University of Cincinnati study: Long-term stroke survival improving, but racial

University of Cincinnati study: Long-term stroke survival improving, but racial disparities remain

  • Mothers who receive childcare support from maternal grandparents show more optimized

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27656 shares
    Share 11059 Tweet 6912
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    1061 shares
    Share 424 Tweet 265
  • Bee body mass, pathogens and local climate influence heat tolerance

    682 shares
    Share 273 Tweet 171
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    546 shares
    Share 218 Tweet 137
  • Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function

    531 shares
    Share 212 Tweet 133
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Most Australian women wearing shoes that don’t match their feet, study finds
  • Ant colonies show varied disease susceptibility and grooming across social levels
  • Leptospira bacteria detected in cattle and rodents across Papua New Guinea provinces
  • Do Parents and Teachers Agree on Preschool Dual Language Learners’ Social Skills?

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Biotechnology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Editorial Policy
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.

Join 5,150 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine